ASCIA Action, First Aid, Management, Travel and Treatment Plans and Guides


ASCIA Action Plans for Anaphylaxis (RED)

Current ASCIA Action Plans are the General and EpiPen 2021 versions, and the 2022 Anapen version. However, prior versions (2021, 2020 and 2018) are still valid for use in 2022 and 2023. ASCIA Action Plans do not expire, and therefore the plan is still valid beyond the date of review, which is a guide for patients to see their doctor. For further information about ASCIA Action Plans go to www.allergy.org.au/hp/anaphylaxis/action-plans-for-allergic-reactions-faq 

ASCIA Action Plan for Anaphylaxis (RED) 2021 EpiPen®

This plan is provided to people with allergies who have been prescribed EpiPen® adrenaline injectors.

This plan is not for allergic rhinitis (hay fever) due to pollen, dust mite, animals or other inhaled allergens.

pdfASCIA Action Plan Anaphylaxis EpiPen Red 2021

ASCIA Action Plan for Anaphylaxis (RED) 2022 Anapen®

This plan is provided to people with allergies who have been prescribed Anapen® adrenaline injectors.

This plan is not for allergic rhinitis (hay fever) due to pollen, dust mite, animals or other inhaled allergens.

pdfASCIA Action Plan Anaphylaxis Anapen Red 2022

ASCIA Action Plan for Anaphylaxis (RED) 2021 General with QR Code

This plan is provided to people with allergies who have been prescribed any brand of adrenaline injectors. 

This plan is not for allergic rhinitis (hay fever) due to pollen, dust mite, animals or other inhaled allergens.

pdfASCIA Action Plan Anaphylaxis General Red 2021 with QR Code

How to give adrenaline injectors (Anapen® and EpiPen®)

This document can be printed as a poster, and used with the generic versions of ASCIA Action Plans or First Aid Plans for Anaphylaxis.

pdfASCIA PCC How to give Adrenaline Injectors 2022 
 

ASCIA Action Plan for Drug (Medication) Allergy and Record

ASCIA Action Plan for Drug (Medication) Allergy

This plan is provided to people with drug (medication) allergies who are not usually prescribed an adrenaline injector, because accidental exposure to drugs can mostly be avoided. They are usually recommended to wear medical identification, to avoid exposure to drugs used in medical procedures. 

pdfASCIA Action Plan for Drug (Medication) Allergy  

ASCIA Record for Drug (Medication) Allergy

pdfASCIA Record for Drug (Medication) Allergy

ASCIA Action Plan for Allergic Reactions (GREEN) 2021

ASCIA Action Plan for Allergic Reactions (GREEN) 2021

This plan is provided to people with allergies who have not been prescribed adrenaline injector/s. 

This plan is not for allergic rhinitis (hay fever) due to pollen, dust mite, animals or other inhaled allergens.

pdfASCIA Action Plan Allergic Reactions Green 2021

An ASCIA Action Plan for Anaphylaxis for use with adrenaline autoinjectors on airlines is available upon request. This plan is should be stored with adrenaline autoinjectors in emergency medical kits on airlines. 

ASCIA First Aid Plans for Anaphylaxis (ORANGE)

Note: These have replaced the general versions of ASCIA Action Plans for Anaphylaxis (ORANGE)

ASCIA First Aid Plan for Anaphylaxis (ORANGE) 2021 EpiPen®

This plan can be used as a poster or stored with general use EpiPen® adrenaline autoinjectors.

pdfASCIA First Aid Anaphylaxis EpiPen Orange 2021

ASCIA First Aid Plan for Anaphylaxis (ORANGE) 2022 Anapen®

This plan can be used as a poster or stored with general use Anapen® adrenaline autoinjectors.

pdfASCIA First Aid Anaphylaxis Anapen Orange 2022

ASCIA First Aid Plan for Anaphylaxis (ORANGE) 2021 General with QR Code

This plan can be used as a poster or stored with general use adrenaline autoinjectors. 

pdfASCIA First Aid Anaphylaxis General Orange 2021 with QR Code

ASCIA First Aid Plan for Anaphylaxis (ORANGE) 2021 Pictorial Poster

The ASCIA Action Plan is best viewed when printed as an A3 poster.

pdfASCIA First Aid Anaphylaxis Generic Orange 2021 poster

For translated versions of ASCIA First Aid for Anaphylaxis go to www.allergy.org.au/hp/anaphylaxis#ta5

For further information about ASCIA Action Plans and other anaphylaxis resources go to www.allergy.org.au/anaphylaxis   

ASCIA Travel Plan and Checklist

ASCIA Travel Plan for people at risk of anaphylaxis

pdfASCIA Travel Plan Anaphylaxis 2021

ASCIA Travelling with allergy, asthma and anaphylaxis checklist

pdfASCIA Checklist: Travelling with allergy, asthma or anaphylaxis 2021

ASCIA Action Plan for Eczema and Guide to Eczema Management

ASCIA Action Plan
for Eczema 

pdfASCIA Action Plan for Eczema

ASCIA Stepwise Management
Plan for Eczema

pdfASCIA Stepwise Management Plan for Eczema 2022

ASCIA Action Plan for Eosinophilic Oesophagitis (EoE) and Management Plan Eosinophilic Oesophagitis (EoE)

ASCIA Action Plan
for EoE 

pdfASCIA Action Plan for EoE

ASCIA Management Plan
for EoE

pdfASCIA Management Plan EoE

ASCIA Action Plan for FPIES (food protein-induced enterocolitis syndrome) 

ASCIA Action Plan for FPIES (food protein-induced enterocolitis syndrome) 

pdfASCIA Action Plan FPIES 2021 

ASCIA Immunodeficency Plans 

ASCIA SCIg (subcutaneous immunoglobulin) Treatment Plan

pdfASCIA SCIg Treatment Plan 

ASCIA Transfer Care Plan for patients on IRT (immunoglobulin replacement therapy) 

pdfASCIA Transfer Care Plan for patients on IRT (immunoglobulin replacement therapy) 

ASCIA Travel Plan for patients on SCIg (subcutaneous immunoglobulin) therapy

pdfASCIA Travel Plan for patients on SCIg (subcutaneous immunoglobulin) therapy

ASCIA Management Plan for Hereditary Angioedema (HAE)

 ASCIA Treatment Plan for Allergic Rhinitis

 ASCIA Treatment Plans for Immunotherapy

Content updated December 2022

Mod ASCIA Member
Donate to AIFA
go to NAC website
About ASCIA

ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases

Quick Links

About ASCIA

ASCIA is a registered trademark of the Australasian Society of Clinical Immunology and Allergy. All content is subject to copyright for the Australasian Society of Clinical Immunology and Allergy. Read more...

The content for the website is developed and approved by ASCIA Committee and ASCIA Working Party Members. Read more...

Disclaimer I Privacy

The ASCIA website is intended for use by ASCIA members, health professionals and the general public. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...

ASCIA respects your privacy. Read our privacy policy here...

Sponsors | Advertising

ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites. 

The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.

Information Partner

Official Information Partner of Healthdirect Australia